$455,000: “A Mouse Model to Test the Effects of Gender-affirming Hormone Therapy on HIV Vaccine-induced Immune Responses”
$2,500,000: “Reproductive Consequences of Steroid Hormone Administration”
“These mice manifest defects in ovarian architecture and have altered folliculogenesis.”
$299,940: “Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment Outcomes”
“We will compare the incidences and tumor specific survival in female mice (intact) and oophorectomized female mice receiving TT with their respective counterparts that do not receive TT.”
$735,113: “Microbiome mediated effects of gender affirming hormone therapy in mice”
$1,200,000: “Androgen effects on the reproductive neuroendocrine axis”
“Aim 2 utilizes transgenic mice to test whether male-level androgens acting via AR specifically in kisspeptin neurons are necessary and/or sufficient for androgen inhibition of in vivo LH pulse parameters, including pulse frequency, and the estrogen-induced LH surge.”
$3,100,000: “Gonadal hormones as mediators of sex and gender influences in asthma”
“We will study the contributions of estrogens to HDM-induced asthma outcomes using male and female gonadectomized mice treated with estradiol…”
Testing Gender and Transrelated Medicine is not “Making Mice Transgender”.
But yes, the spending was to test a medical treatment, the same way how many medical treatments are tested. He is opposing this specific research for ideological reasons, of course.
Hate to say it, but he was actually right on this one. https://pubmed.ncbi.nlm.nih.gov/36484619/
$455,000: “A Mouse Model to Test the Effects of Gender-affirming Hormone Therapy on HIV Vaccine-induced Immune Responses”
$2,500,000: “Reproductive Consequences of Steroid Hormone Administration” “These mice manifest defects in ovarian architecture and have altered folliculogenesis.”
$299,940: “Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment Outcomes” “We will compare the incidences and tumor specific survival in female mice (intact) and oophorectomized female mice receiving TT with their respective counterparts that do not receive TT.”
$735,113: “Microbiome mediated effects of gender affirming hormone therapy in mice”
$1,200,000: “Androgen effects on the reproductive neuroendocrine axis” “Aim 2 utilizes transgenic mice to test whether male-level androgens acting via AR specifically in kisspeptin neurons are necessary and/or sufficient for androgen inhibition of in vivo LH pulse parameters, including pulse frequency, and the estrogen-induced LH surge.”
$3,100,000: “Gonadal hormones as mediators of sex and gender influences in asthma” “We will study the contributions of estrogens to HDM-induced asthma outcomes using male and female gonadectomized mice treated with estradiol…”
Testing Gender and Transrelated Medicine is not “Making Mice Transgender”.
But yes, the spending was to test a medical treatment, the same way how many medical treatments are tested. He is opposing this specific research for ideological reasons, of course.